Cargando…
Retaining Patients with Drug-Resistant Tuberculosis on Treatment During the COVID-19 Pandemic — Dharavi, Mumbai, India, 2020–2022
Autores principales: | Gomare, Mangala D., Bhide, Sampada, Deshmukh, Rajesh, Kaipilyawar, Satish, Puri, Varsha, Moonan, Patrick K., Khetade, Dilip K., Nyendak, Melissa, Yeldandi, Vijay, Smith, Jonathan P., Tobias, James L., Date, Anand, Joshi, Rajendra, Kumar, Ravinder, Ho, Christine S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042620/ https://www.ncbi.nlm.nih.gov/pubmed/36952291 http://dx.doi.org/10.15585/mmwr.mm7212a2 |
Ejemplares similares
-
COVID-19 Containment in Asia’s Largest Urban Slum Dharavi-Mumbai, India: Lessons for Policymakers Globally
por: Golechha, Mahaveer
Publicado: (2020) -
Conflict, Crisis, and Abuse in Dharavi, Mumbai: Experiences from Six Years at a Centre for Vulnerable Women and Children
por: Daruwalla, Nayreen, et al.
Publicado: (2009) -
Interventions to respond to COVID 19 pandemic in Mumbai and way forward
por: Khaparde, Sunil, et al.
Publicado: (2022) -
Tuberculosis diagnosis and management in the public versus private sector: a standardised patients study in Mumbai, India
por: Daniels, Benjamin, et al.
Publicado: (2022) -
COVID-19 Serological Survey-3 Prior to Second Wave in Mumbai, India
por: Velhal, Gajanan D., et al.
Publicado: (2022)